Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer

BACKGROUND: Molecular cancer profiling may lead to appropriate trials for molecularly targeted therapies. Cell-free DNA (cfDNA) is a promising diagnostic and/or prognostic biomarker in gastric cancer (GC). We characterized somatic genomic alterations in cfDNA of patients with GC. METHODS: Medical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Boyeon, Kim, Yoonjung, Cho, Jae Yong, Lee, Kyung-A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2024
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628753/
https://www.ncbi.nlm.nih.gov/pubmed/37903652
http://dx.doi.org/10.3343/alm.2023.0187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628753/
https://www.ncbi.nlm.nih.gov/pubmed/37903652
http://dx.doi.org/10.3343/alm.2023.0187

Ejemplares similares